C4A and schizophrenia: Current studies have identified elevated transcript levels of complement components (C1qA, C3, C4, C5) in patients with schizophrenia (114) (see Table 2), suggesting, albeit not entirely consistently, that increased activation of the classical complement pathway may be associated with SZ.